Pinnacle Financial Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $1.22M | Buy |
2,932
+45
| +2% | +$18.7K | 0.02% | 262 |
|
2024
Q4 | $1.19M | Sell |
2,887
-58
| -2% | -$23.9K | 0.02% | 262 |
|
2024
Q3 | $1.53M | Buy |
2,945
+47
| +2% | +$24.4K | 0.03% | 246 |
|
2024
Q2 | $1.55M | Sell |
2,898
-46
| -2% | -$24.6K | 0.03% | 244 |
|
2024
Q1 | $1.53M | Sell |
2,944
-141
| -5% | -$73.1K | 0.03% | 237 |
|
2023
Q4 | $1.45M | Sell |
3,085
-141
| -4% | -$66.5K | 0.03% | 233 |
|
2023
Q3 | $1.4M | Buy |
3,226
+128
| +4% | +$55.7K | 0.04% | 227 |
|
2023
Q2 | $1.38M | Buy |
3,098
+13
| +0.4% | +$5.78K | 0.03% | 223 |
|
2023
Q1 | $1.42M | Buy |
3,085
+300
| +11% | +$138K | 0.04% | 220 |
|
2022
Q4 | $1.43M | Sell |
2,785
-115
| -4% | -$59K | 0.04% | 217 |
|
2022
Q3 | $1.32M | Buy |
2,900
+90
| +3% | +$40.9K | 0.05% | 216 |
|
2022
Q2 | $1.36M | Buy |
2,810
+61
| +2% | +$29.4K | 0.05% | 210 |
|
2022
Q1 | $1.35M | Sell |
2,749
-19
| -0.7% | -$9.34K | 0.04% | 217 |
|
2021
Q4 | $1.28M | Buy |
2,768
+1,010
| +57% | +$468K | 0.04% | 222 |
|
2021
Q3 | $655K | Buy |
1,758
+25
| +1% | +$9.32K | 0.02% | 258 |
|
2021
Q2 | $661K | Sell |
1,733
-25
| -1% | -$9.54K | 0.03% | 245 |
|
2021
Q1 | $600K | Buy |
1,758
+18
| +1% | +$6.14K | 0.03% | 243 |
|
2020
Q4 | $515K | Buy |
1,740
+34
| +2% | +$10.1K | 0.03% | 247 |
|
2020
Q3 | $458K | Sell |
1,706
-1,738
| -50% | -$467K | 0.02% | 247 |
|
2020
Q2 | $906K | Buy |
3,444
+215
| +7% | +$56.6K | 0.05% | 200 |
|
2020
Q1 | $732K | Buy |
3,229
+757
| +31% | +$172K | 0.05% | 210 |
|
2019
Q4 | $746K | Buy |
2,472
+964
| +64% | +$291K | 0.05% | 228 |
|
2019
Q3 | $362K | Buy |
+1,508
| New | +$362K | 0.03% | 270 |
|
2018
Q3 | – | Sell |
-26
| Closed | -$6K | – | 436 |
|
2018
Q2 | $6K | Hold |
26
| – | – | ﹤0.01% | 383 |
|
2018
Q1 | $6K | Buy |
+26
| New | +$6K | ﹤0.01% | 389 |
|
2017
Q3 | – | Sell |
-400
| Closed | -$75K | – | 326 |
|
2017
Q2 | $75K | Buy |
+400
| New | +$75K | 0.01% | 316 |
|